Litcius/Paper detail

Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer

Lisha Bao, Ying Li, Xiaoping Hu, Yingying Gong, Jinming Chen, Ping Huang, Zhuo Tan, Minghua Ge, Zongfu Pan

2024International Immunopharmacology17 citationsDOI

Topics & Concepts

Anaplastic thyroid cancerImmunotherapyMedicineCancer immunotherapyCancerCancer researchThyroid cancerOncologyImmunologyInternal medicineImmunotherapy and Immune ResponsesCancer Immunotherapy and BiomarkersUbiquitin and proteasome pathways
Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer | Litcius